EP2467372
Meðferð við BDNF-tengdum röskunum með því að nota laquinimod
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
9.8.2010EP published:
18.5.2016EP application number:
10808442.7
EP translation filed:
8.8.2016Grant published:
15.9.2016EPO information:
European Patent Register
Max expiry date:
8.8.2030Expiry date:
8.8.2019
Title:
TREATMENT OF BDNF-RELATED DISORDERS USING LAQUINIMOD
Timeline
Today
9.8.2010EP application
18.5.2016EP Publication
8.8.2016Translation submitted
15.9.2016Registration published
8.8.2019Expires
Owner
Name:
Teva Pharmaceutical Industries Ltd.Address:
5 Basel Street P.O. Box 3190, 49131, Petah Tiqva, IL
Inventor
Name:
HAYARDENY, LiatAddress:
Tel Aviv, IL
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
273920 PDate:
10.8.2009Country:
US
Classification
Categories:
A61K 31/4704, A61P 25/00, A61P 25/16, A61P 25/18, A61P 25/22, A61P 25/24, A61P 25/28, A61K 31/138, A61K 31/428
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 20.7.2016
Expires: 8.8.2017
Payer: G. H. Sigurgeirsson
Number: 8
Paid: 20.7.2017
Expires: 8.8.2018
Payer: G. H. Sigurgeirsson
Number: 9
Paid: 18.7.2018
Expires: 8.8.2019
Payer: G. H. Sigurgeirsson